Alnylam Pharmaceuticals, Inc.

LPL Financial LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

45,919

Value ($000)

18,259

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	18,259	0.0%	45,919	12/31/2025
2025 Q3	11/12/2025	22,107	0.0%	48,480	9/30/2025
2025 Q2	8/12/2025	9,893	0.0%	30,339	6/30/2025
2025 Q1	5/7/2025	5,584	0.0%	20,679	3/31/2025
2024 Q4	2/11/2025	4,370	0.0%	18,572	12/31/2024
2024 Q3	11/8/2024	5,172	0.0%	18,806	9/30/2024
2024 Q2	8/7/2024	4,529	0.0%	18,636	6/30/2024
2024 Q1	5/10/2024	2,537	0.0%	16,974	3/31/2024
2023 Q4	2/14/2024	3,201	0.0%	16,721	12/31/2023
2023 Q3	11/13/2023	2,793	0.0%	15,770	9/30/2023
2023 Q2	7/31/2023	2,825	0.0%	14,875	6/30/2023
2023 Q1	5/10/2023	2,947	0.0%	14,710	3/31/2023
2022 Q4	2/7/2023	3,276	0.0%	13,785	12/31/2022
2022 Q3	11/14/2022	2,650	0.0%	13,238	9/30/2022
2022 Q2	8/12/2022	1,719	0.0%	11,783	6/30/2022
2022 Q1	5/16/2022	2,712	0.0%	16,608	3/31/2022
2021 Q4	2/14/2022	2,695	0.0%	15,894	12/31/2021
2021 Q3	11/15/2021	2,474	0.0%	13,102	9/30/2021
2021 Q2	8/13/2021	1,737	0.0%	10,244	6/30/2021
2021 Q1	5/14/2021	1,285	0.0%	9,101	3/31/2021
2020 Q4	2/12/2021	725	0.0%	5,582	12/31/2020
2020 Q3	11/9/2020	827	0.0%	5,680	9/30/2020
2020 Q2	8/13/2020	788	0.0%	5,320	6/30/2020
2020 Q1	5/14/2020	516	0.0%	4,743	3/31/2020
2019 Q4	2/14/2020	534	0.0%	4,635	12/31/2019
2014 Q2	8/5/2014	510	0.0%	8,076	6/30/2014
2014 Q1	5/12/2014	1,117	0.0%	16,634	3/31/2014
2013 Q4	2/13/2014	829	0.0%	12,888	12/31/2013